{
  "variant_id": {
    "Gene": "PSEN1",
    "Protein_Change": {
      "ref": "D",
      "alt": "N",
      "position": "141"
    },
    "variant_string_id": "PSEN1 D141N"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "The study investigates the binding of PSEN1 with PSEN2 and its role in Alzheimer's disease pathology. The variant PSEN1 D141N is examined for its effect on this interaction.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism, linking the variant to a functional deficit in binding that could contribute to Alzheimer's disease."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "Enzyme activity assays and co-immunoprecipitation were used to assess binding and enzymatic function.",
      "judgment": "Yes",
      "reasoning": "The enzyme activity assay and protein interaction assay are standard methods for studying gamma-secretase complex functionality, directly modeling the disease mechanism."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Basic controls (wild-type PSEN1) were used, but no explicit mention of multiple replicates or variant controls.",
      "judgment": "No",
      "reasoning": "While basic controls were included, there is insufficient information on the use of both normal and abnormal variants as controls."
    },
    {
      "step_name": "Sub-step 3b: Accepted/Validated Assay",
      "extracted_paper_info": "The assays used are widely accepted in the field for studying gamma-secretase activity and protein interactions.",
      "judgment": "Yes",
      "reasoning": "The enzyme activity assay is a broadly accepted method, validating its applicability despite insufficient basic controls."
    },
    {
      "step_name": "Sub-step 3c: Variant Controls",
      "extracted_paper_info": "No known pathogenic or benign variant controls were explicitly mentioned for this assay.",
      "judgment": "No",
      "reasoning": "The paper does not describe the use of variant controls, limiting the strength of the evidence."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "No statistical analyses or OddsPath calculations were provided for this variant.",
      "judgment": "No",
      "reasoning": "The lack of statistical analysis limits the ability to assign a quantitative measure of pathogenicity."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "The functional assay supports the pathogenic nature of PSEN1 D141N, but the lack of detailed controls and statistical analysis limits the evidence to a supporting level."
}